Reglan

Reglan (metoclopramide) is used to treat gastrointestinal disorders and nausea. Research has shown Reglan can significantly increase the risk of developing a neurological syndrome called tardive dyskinesia. Tardive dyskinesia causes involuntary repetitive movements.

The Food and Drug Administration began requiring Reglan and other metoclopramide drugs to carry a black box warning alerting consumers to the risk in February of 2009.  Lawyers are pursuing litigation on behalf of patients affected by Reglan or metoclopramide use.

Show More
Back to top button